Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED) and dysfunction is widely thought to mechanistically involve ductal hyperkeratinization, plugging and ...

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

DEAR DR. ROACH: I’m a 65-year-old female, non-smoker, with very dry eyes living in a dry climate. My eyes often burn and tear up, which I find curious, having been diagnosed with dry eyes. During the ...

Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...

The National Eye Institute, part of the National Institutes of Health, awarded Jason J. Nichols, OD, MPH, PhD, FAAO, a five-year, $1.9 million R01 grant to study potential molecular markers in ...

Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Please provide your email address to receive an email when new articles are posted on . Both treatment groups had sustained improvements in OSDI, Dry Eye Questionnaire and Symptom Assessment in Dry ...

Handheld and portable, the iLux Device enables eye care professionals to directly target a patient's blocked meibomian glands and provide therapy through an in-office treatment. Using the iLux Device, ...

SAN DIEGO — Omega-3 fatty acid supplementation improves the signs and symptoms of meibomian gland dysfunction, a new study shows. This study supports the potential of omega-3 fatty acids to prevent ...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular ...